(ALX) Alexanders - Ratings and Ratios

Alexanders, Inc. is a real estate investment trust (REIT) that specializes in leasing, managing, and redeveloping properties in the New York City metropolitan area. The company operates through its manager, Vornado Realty Trust, and has a portfolio of five key properties, including the prestigious 731 Lexington Avenue office and retail complex, which serves as the world headquarters for Bloomberg, L.P.

The companys properties are strategically located in high-demand areas, with 731 Lexington Avenue being a prime example of a high-quality asset that generates significant rental income. Additionally, Alexanders has a presence in Queens with the Rego Center complex, which includes retail properties and a luxury apartment tower, The Alexander. The companys retail property in Flushing, NY, further diversifies its portfolio.

From a financial perspective, Alexanders has demonstrated a strong track record of performance, with a return on equity (RoE) of 21.34%. The companys market capitalization stands at $1.17 billion, with a price-to-earnings (P/E) ratio of 29.69. While the forward P/E ratio is not available, the current valuation suggests that investors are willing to pay a premium for the companys shares, likely due to its stable cash flows and growth prospects.

Analyzing the technical data, Alexanders stock price is currently trading at $226.46, with a 20-day simple moving average (SMA) of $224.62 and a 50-day SMA of $211.81. The stock is also above its 200-day SMA of $207.62, indicating a longer-term uptrend. The average true range (ATR) is $5.26, representing a 2.32% daily price movement. Given the current technical and fundamental data, a forecast for Alexanders stock price could be moderately bullish, with potential for the stock to reach $240 in the near term, driven by its strong fundamentals and favorable technical indicators.

Based on the analysis, it is likely that Alexanders will continue to benefit from its high-quality properties and strong management, driving long-term value creation for shareholders. As the company continues to optimize its portfolio and capitalize on growth opportunities, investors may want to consider accumulating shares of ALX, with a target price of $240.